RecruitingNot ApplicableNCT07279545

The Effect of Placental Cord Drainage on the Third Stage of Labor and the Amount of Postpartum Bleeding


Sponsor

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Enrollment

80 participants

Start Date

Nov 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study was to evaluate the effect of controlled placental cord drainage by opening the clamp at the maternal end after the umbilical cord is cut during birth on the duration of the third stage of labor (departure of the placenta), the amount of blood loss in the third stage, the amount of bleeding in the 2nd hour postpartum, and the development of postpartum complications.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 35 Years

Inclusion Criteria6

  • No problem speaking and understanding Turkish
  • Low-risk pregnant women
  • Vertex presentation
  • st weeks of gestation
  • There are no complications in the mother or the baby that prevent normal birth.
  • The VAS score for the pain felt by the pregnant woman at the time of admission to the study must be less than 3 (to show that the pregnant women were accepted into the study at a time when their pain was at its lowest and their decision-making ability was at a relatively good level)

Exclusion Criteria7

  • History of postpartum hemorrhage
  • History of postpartum hemorrhage in mother or sister
  • Birth interval less than 2 years
  • Anticoagulant use during pregnancy
  • Smoking during pregnancy
  • Those with low Hb values (Hb\<11gr/dL)
  • Hematocrit \<30

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPlacental cord drainage

Placental cord drainage is the process of clamping and cutting the umbilical cord after the birth of the baby, then opening the clamp at the maternal end of the cord and allowing the blood in the placenta to flow outward (Soltani et al, 2011; Vasconcelos et al, 2018; Pandey et al, 2019; Upadya et al, 2019; Chaudhary et al, 2020; Kazı et al, 2020; Mittal et al, 2020; Nabıl and Marzouk, 2020; Mansour et al, 2021; El Sayed et al, 2021; Karimi et al, 2022; Wedn and Hassanin, 2022).


Locations(1)

Zonguldak Maternity and Child Diseases Hospital

Zonguldak, Zonguldak/Centre, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07279545


Related Trials